From Slow-Healing Wounds to Tissue Repair: How Laser Therapy Is Changing Wound Care
victoria smith
Slow-healing wounds are a major challenge in modern healthcare. From diabetic foot ulcers and pressure injuries to surgical wounds that fail to close as expected, delayed tissue repair can increase the risk of infection, prolong recovery, and significantly affect quality of life. Traditional wound care remains essential, but researchers are increasingly investigating complementary approaches that may help the body repair damaged tissue more efficiently.
Laser therapy for wound healing, particularly low-level laser therapy (LLLT) and photobiomodulation therapy (PBMT), has attracted attention for its potential to support cellular activity, reduce wound size, and improve healing outcomes. Clinical research has reported encouraging results, especially in patients with diabetic foot ulcers. A 2021 meta-analysis of 13 randomized controlled trials involving 413 patients found that low-level laser therapy was associated with higher complete-healing rates, smaller ulcer areas, and shorter healing times compared with control treatments. However, the researchers rated the overall evidence quality as very low, highlighting the need for further high-quality trials.
Understanding how laser therapy works, what clinical studies have demonstrated, and how treatment outcomes should be measured helps healthcare professionals evaluate its role in modern wound management.
1. How Laser Therapy for Wound Healing Helps Slow-Healing Wounds Recover Faster
1.1 What Is Laser Therapy for Wound Healing? Understanding Low-Level Laser Therapy
Laser therapy for wound healing uses specific wavelengths of light to interact with biological tissue. Low-level laser therapy, often discussed alongside photobiomodulation therapy, delivers light at selected parameters intended to stimulate cellular responses without relying on the destructive heating associated with surgical lasers.
Red and near-infrared wavelengths are commonly investigated in photobiomodulation research. Depending on the wavelength and treatment parameters, light may influence mitochondrial signaling, cellular energy metabolism, oxidative stress responses, and biological processes involved in tissue repair.
Wound healing requires several coordinated stages: inflammation, tissue formation, and remodeling. Fibroblasts contribute to collagen production and extracellular matrix formation, while new blood vessel development helps supply oxygen and nutrients to repairing tissue. Keratinocytes support the restoration of the skin's protective surface.
Photobiomodulation may influence some of these processes, potentially helping create a more favorable environment for repair. Its effects depend on the tissue being treated, wavelength, energy delivered, treatment frequency, and the patient's underlying condition.
Importantly, low-level laser therapy is different from high-power surgical laser treatment. Its intended purpose is to modulate biological responses rather than cut, vaporize, or deliberately destroy tissue.
1.2 Why Do Chronic Wounds Heal Slowly? Common Causes of Delayed Wound Healing
A wound may remain open when the normal repair process is interrupted. Diabetes is a particularly important risk factor because elevated blood glucose, impaired circulation, neuropathy, and altered immune responses can all contribute to delayed healing.
Diabetic foot ulcers illustrate this challenge. Reduced sensation may prevent patients from noticing repeated pressure or minor injuries, while poor circulation can limit the oxygen and nutrients available to damaged tissue. Continued pressure on the affected area may further prevent closure.
Other common causes of chronic wounds include venous insufficiency, pressure injuries, inadequate nutrition, infection, and underlying vascular disease. Persistent inflammation can also interfere with the transition from the inflammatory phase to tissue formation and remodeling.
Effective wound management therefore requires more than a single treatment. Depending on the wound, care may include debridement, appropriate dressings, infection management, pressure offloading, compression therapy, or assessment of blood flow.
Laser therapy is being studied as an adjunct to standard wound care. Its potential value lies in supporting biological repair while clinicians address the underlying reasons a wound is not healing.
1.3 Laser Therapy vs. Standard Wound Care: What Does Clinical Research Show?
The most useful way to assess laser therapy is to compare outcomes between patients receiving laser treatment alongside standard care and those receiving standard care or control treatment alone.
A 2021 meta-analysis by Huang and colleagues included 13 randomized controlled trials with 413 patients who had diabetic foot ulcers. Compared with the control groups, the low-level laser therapy groups had a higher complete-healing rate, with a pooled risk ratio of 2.10 (95% confidence interval 1.56–2.83). The analysis also reported statistically significant improvements in ulcer area and mean healing time.
A risk ratio of 2.10 means that the relative likelihood of complete healing was approximately 2.1 times that of the control group in the pooled analysis. It does not mean that every patient healed twice as quickly or that every wound will close.
The distinction matters because individual results depend on wound severity, circulation, diabetes management, treatment parameters, and study design. The authors also emphasized that the overall evidence quality was very low.
Nevertheless, these findings provide a clinical rationale for further investigating laser therapy as a complementary wound-care intervention, particularly for difficult-to-heal diabetic foot ulcers.
2. Photobiomodulation Therapy for Wound Healing: Clinical Evidence of Tissue Repair
2.1 How Photobiomodulation Therapy Supports Cellular Repair and Wound Healing
Photobiomodulation therapy is based on the principle that appropriately delivered light can influence cellular signaling and biological activity. Rather than mechanically closing a wound, it aims to support the processes that allow the body to restore damaged tissue.
One proposed mechanism involves mitochondrial activity and cellular energy metabolism. Light absorption may influence signaling pathways associated with ATP production, reactive oxygen species, and other cellular responses. These processes are involved in regulating inflammation, cell migration, and tissue regeneration.
Photobiomodulation research also investigates fibroblast activity, collagen organization, and angiogenesis, the formation of new blood vessels. These mechanisms are relevant because wound closure depends on rebuilding the tissue beneath the surface as well as restoring the outer skin layer.
A 2024 systematic review by Pilar and colleagues examined changes in gene expression during skin wound repair following photobiomodulation in in-vivo studies. The review investigated molecular responses associated with wound healing while noting that the underlying biological effects are not yet fully understood. Because this review focused on in-vivo studies, its findings should not be interpreted as direct proof of improved healing rates in human patients.
The clinical significance is that photobiomodulation may affect multiple aspects of the wound-healing process. However, proposed cellular mechanisms and demonstrated patient outcomes are different forms of evidence and should be evaluated separately.
2.2 Laser Therapy for Diabetic Foot Ulcers: Wound Size Reduction and Healing Rates
Diabetic foot ulcers are among the most frequently investigated applications of low-level laser therapy. These wounds can remain open for extended periods, and delayed healing increases the risk of complications, including infection and hospitalization.
A systematic review and meta-analysis by Zhou and colleagues, published in Wound Repair and Regeneration in 2021, included 12 randomized controlled trials evaluating low-level light therapy for diabetic foot ulcers.
The researchers reported that the treatment group had a 30.90% greater reduction in ulcer area than the control group in the pooled comparison. They also reported an additional ulcer-area reduction of 4.2 cm² in a separate pooled analysis. The review found that ulcers in the treatment group were 4.65 times more likely to heal completely than those in the control group.
These findings offer a meaningful comparison between treatment approaches. Instead of relying only on subjective impressions, clinicians can evaluate changes in wound dimensions and the proportion of wounds that achieve complete closure.
The reported effect sizes should be interpreted in the context of the original review. They are pooled estimates, not guaranteed results for an individual patient, and they should not be combined into a single predicted outcome. Differences in laser protocols, follow-up periods, and patient characteristics can affect results.
Even with these qualifications, the research suggests that low-level light therapy may provide additional benefits when incorporated into a comprehensive diabetic foot ulcer management plan.
2.3 Before-and-After Wound Healing: Measuring Tissue Repair with Clinical Outcomes
Before-and-after wound measurements are essential for determining whether a treatment is producing meaningful progress. A photograph alone may show visible changes, but standardized clinical measurements provide a stronger basis for comparison.
At baseline, clinicians can record wound length, width, area, depth, tissue appearance, and relevant patient factors. Follow-up assessments can then document whether the wound is becoming smaller, developing healthy granulation tissue, and progressing toward epithelialization.
Percentage wound-area reduction can be calculated using the following formula:
For example, if a wound decreases from 10 cm² to 7 cm², its area has decreased by 30%. This is an illustrative calculation, not a result from a clinical trial.
A robust before-and-after comparison should also record complete wound closure, time to healing, pain where relevant, and adverse events. Whenever possible, treatment outcomes should be compared with a control group receiving appropriate standard care.
This approach helps distinguish genuine clinical improvement from normal variation, changes in wound measurement, or the effects of other treatments delivered at the same time.
3. Laser Therapy for Chronic Wounds: From Diabetic Foot Ulcers to Pressure Sores
3.1 Laser Therapy for Diabetic Foot Ulcers: Supporting Wound Closure
Diabetic foot ulcers are a logical focus for laser wound-healing research because they combine impaired tissue repair with substantial clinical risks. Low-level laser therapy may offer an additional means of supporting wound-area reduction and complete closure in selected patients.
However, treatment should be integrated with the measures that directly address diabetic foot ulcer causes. These include pressure offloading, regular wound assessment, glucose management, circulation evaluation, and appropriate infection treatment.
A wound that is not improving requires reassessment rather than simply increasing the frequency or intensity of laser exposure. Severe ischemia, spreading infection, or suspected deep tissue involvement may require urgent medical or surgical intervention.
The available meta-analyses provide encouraging evidence for adjunctive treatment, but they do not establish a universally effective protocol for every diabetic foot ulcer. Clinicians should select treatment parameters based on appropriate evidence, device instructions, and the patient's clinical circumstances.
3.2 Laser Therapy for Pressure Ulcers and Bedsores: Supporting Tissue Recovery
Pressure ulcers develop when sustained pressure or pressure combined with shear damages skin and underlying tissue. They commonly affect areas such as the heels, sacrum, and hips, particularly in people with limited mobility.
The foundation of pressure-ulcer management is relieving pressure, repositioning when appropriate, maintaining a suitable wound environment, and addressing nutrition and other factors that impair healing.
Photobiomodulation is being investigated as a complementary intervention that may influence inflammation and tissue repair. Potential outcomes include changes in wound dimensions, granulation tissue, and time to closure.
Nevertheless, evidence from diabetic foot ulcer studies cannot automatically be applied to pressure injuries. These wound types have different causes and clinical management requirements, and the strength of evidence may differ considerably.
A sound clinical approach is to assess pressure-ulcer research directly and evaluate laser therapy against measurable outcomes rather than assuming that improvements in one wound category will occur in another.
3.3 Laser Therapy for Surgical Wounds and Nonhealing Skin Wounds
Surgical wounds normally progress through a coordinated repair process, but complications such as infection, excessive tension, poor circulation, and underlying disease can delay closure.
Laser therapy and photobiomodulation have been investigated for their potential effects on postoperative healing, inflammation, and tissue remodeling. Other areas of interest include traumatic skin wounds and wounds that remain open despite conventional treatment.
The evidence must be assessed according to the type of wound and the outcome being studied. Faster early epithelialization, reduced wound dimensions, improved scar appearance, and complete closure are distinct endpoints.
For example, a study reporting reduced inflammation does not necessarily establish a shorter time to complete healing. Likewise, findings from animal experiments cannot establish the same clinical benefit in human patients.
Future clinical trials should specify wound type, treatment wavelength, energy density, treatment schedule, comparison group, and follow-up period. Such consistency would make it easier for healthcare professionals to compare studies and identify appropriate applications.
4. Laser Wound Healing Treatment Parameters: Wavelength, Dosage, and Clinical Protocols
4.1 Best Wavelength for Laser Therapy for Wound Healing: Red Light vs. Near-Infrared Light
Wavelength is an important consideration in laser therapy because it influences how light interacts with biological tissue. Red and near-infrared wavelengths are commonly investigated in photobiomodulation, but they should not be considered interchangeable across all wound types.
Red light is frequently studied for superficial tissue applications, while near-infrared light is investigated for its potential to deliver energy to deeper tissue. Actual penetration and biological effects depend on wavelength, tissue composition, pigmentation, blood content, and the optical properties of the treatment site.
The best wavelength for wound healing cannot be determined by wavelength alone. Energy density, power density, treatment duration, application geometry, and the patient's condition also influence the treatment delivered.
For this reason, comparisons between laser devices should focus on validated treatment protocols and relevant clinical outcomes. A device that emits a particular wavelength is not automatically more effective than another device using a different wavelength.
4.2 Laser Therapy Dosage for Wound Healing: Power Density, Energy Density, and Treatment Frequency
Appropriate dosing is central to reproducible laser therapy. Several technical measurements help describe how much optical energy reaches the target tissue.
- Power (mW or W): The optical output of the device.
- Irradiance (mW/cm²): Optical power delivered per unit area.
- Fluence (J/cm²): Energy delivered per unit area over a specified exposure.
- Treatment duration: The time light is applied during a session.
Fluence can be calculated by multiplying irradiance in watts per square centimeter by exposure time in seconds. For example, an irradiance of 0.05 W/cm² applied for 200 seconds corresponds to 10 J/cm², assuming constant output and consistent exposure across the treatment area.
This is a mathematical example, not a recommended wound-healing dose.
Treatment frequency, pulse settings, beam size, distance from the tissue, and the number of sessions also matter. Different studies may use substantially different protocols, making direct comparisons difficult.
The 2021 meta-analysis by Huang and colleagues identified promising clinical outcomes but concluded that larger, higher-quality trials were needed to establish the most appropriate treatment parameters.
Consequently, wound-care professionals should follow evidence-based protocols and manufacturer instructions rather than assume that greater power or longer exposure necessarily produces better healing.
4.3 Laser Therapy Safety for Wound Care: Professional Best Practices
Laser therapy should be used within an appropriate clinical framework. Eye protection must match the device's wavelength and output, and clinicians should follow the manufacturer's safety instructions and applicable professional standards.
Wounds should be assessed before and during treatment. Clinicians need to monitor for infection, worsening tissue damage, changes in circulation, and other signs that require a change in the care plan.
Treatment should not delay established interventions such as debridement when indicated, pressure offloading, vascular assessment, or appropriate antimicrobial treatment. Patients with suspected deep infection, severe ischemia, rapidly spreading redness, fever, or rapidly deteriorating wounds need prompt medical assessment.
For chronic wounds, safety also means setting realistic expectations. Laser therapy may offer an additional treatment option, but its role depends on the available clinical evidence, wound characteristics, and the broader management plan.
5. The Future of Laser Therapy in Wound Care: Evidence-Based Tissue Repair and Better Patient Outcomes
5.1 Laser Therapy vs. Conventional Wound Care: Comparing Healing Time and Complete Closure
The most important question is not simply whether a laser produces a biological response, but whether adding it to standard care improves outcomes that matter to patients.
The following findings illustrate how published research has compared treatment outcomes.
These findings should not be treated as direct head-to-head estimates because the two reviews included different trial sets and analytical methods. The relative risk reported by Huang and colleagues also should not be equated directly with the odds ratio reported by Zhou and colleagues.
The broader message is that research has identified potential benefits in several clinically relevant outcomes, particularly for diabetic foot ulcers. However, the very low evidence quality reported in the Huang review means that the magnitude of benefit remains uncertain.
Future research should compare laser therapy plus standard care against standard care alone, using clearly defined treatment parameters and consistent follow-up periods. Studies should report absolute healing rates, time to complete closure, wound-area changes, adverse events, and longer-term outcomes.
5.2 Clinical Research on Laser Therapy for Wound Healing: What Recent Studies Reveal
Research into laser wound healing has progressed beyond documenting visible changes. Investigators are examining the molecular pathways that may explain how photobiomodulation influences tissue repair.
The 2024 systematic review by Pilar and colleagues examined gene-expression changes associated with photobiomodulation during skin wound healing in in-vivo studies. This work contributes to understanding the biological processes that may respond to light-based treatment, although molecular findings do not independently establish clinical effectiveness in humans.
Clinical evidence remains especially important because wounds differ in their causes, severity, and response to treatment. A protocol that appears beneficial for one category of wound may not produce the same result in another.
More robust randomized controlled trials are needed to identify which patients are most likely to benefit, which wavelengths and doses are appropriate, and how laser therapy compares with established treatments. Standardized protocols would also help researchers reproduce results across clinical settings.
In the future, combining objective wound measurements with consistent treatment records may improve clinicians' ability to assess response and adjust care. The goal is not simply to introduce another device, but to identify when laser therapy offers a measurable benefit within evidence-based wound management.
5.3 Is Laser Therapy the Future of Chronic Wound Management?
Laser therapy represents a promising area of research in chronic wound care, particularly for diabetic foot ulcers that are difficult to heal. Published meta-analyses have reported improved wound-area reduction and higher complete-healing rates when low-level light therapy is added to comparison treatment approaches.
Its potential value lies in supporting the body's own repair processes while clinicians address the underlying factors that prevent wounds from healing. Appropriate patient selection, standardized dosing, objective outcome measurement, and continued medical supervision are essential to translating research into clinical practice.
Laser therapy is not a substitute for circulation management, infection control, pressure relief, or appropriate wound dressings. Instead, it may provide an additional tool for selected patients when used alongside established care.
As research develops, the most persuasive evidence will come from well-designed clinical trials that document changes from baseline, compare treatment groups, and report complete healing and time to closure. These measures will help clarify where photobiomodulation can make a meaningful contribution to wound care.
